semaglutide on shortage list FDA Ends Listing, Contributing to Ongoing Legal Challenges Federal judge upholds FDA's removal

In 2023, after a 40 percent rebate, the SHP spent $102.3 million on GLP-1s for weight loss, approximately 10 percent of the programs pharmacy expenditures

Improvements in blood pressure or blood sugar can occur even before massive changes in body weight

Freezing or overheating degrades the peptide compound and makes it unsafe to use

It has proven to help people lose weight and improve their overall health

doi: 10.1056/NEJMoa2307563 [iii] INEGI

This increases cancer risk by two distinct mechanisms both through the promotion of chronic inflammation, and through inhibition of the acute inflammation that is important to halt tumorigenesis (anti-tumor immunity)